SAN
FRANCISCO, Feb. 27, 2024 /PRNewswire/ -- Nektar
Therapeutics (Nasdaq: NKTR) management is scheduled to present at
the upcoming TD Cowen 44th Annual Health Care Conference
in Boston on Tuesday, March 5, 2024 at 2:10 p.m. Eastern Time.
The presentation and Q&A session will be accessible via a
webcast through a link posted on the Investor Events section of the
Nektar website:
https://ir.nektar.com/events-and-presentations/events. This webcast
will be available for replay until April 5,
2024.
About Nektar Therapeutics
Nektar Therapeutics is a
biopharmaceutical company with a robust, wholly owned R&D
pipeline of investigational medicines in immunology and oncology as
well as a portfolio of approved partnered medicines. Nektar is
headquartered in San Francisco,
California, with additional operations in Huntsville, Alabama. Further information about
the company and its drug development programs and capabilities may
be found online at http://www.nektar.com.
Contact:
For Investors:
Vivian
Wu of Nektar Therapeutics
628-895-0661
For Media:
David Rosen
of Argot Partners
(212) 600-1902
david.rosen@argotpartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nektar-management-to-present-at-the-td-cowen-44th-annual-health-care-conference-302073386.html
SOURCE Nektar Therapeutics